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MIMIVIRE is a defense system described in lineage A Mimivirus (Mimiviridae family) that
mediates resistance against Zamilon virophage. It is composed of putative helicase and
nuclease associated with a gene of unknown function called R349, which contains
four 15 bp repeats homologous to the virophage sequence. In a previous study, the
silencing of such genes restored virophage susceptibility. Moreover, the CRISPR Cas-
4 like activity of the nuclease has recently been characterized. In this study, a recently
isolated Mimivirus of lineage A with R349 gene lacking 3 of 4 repeats was demonstrated
to be susceptible to Zamilon. To reinforce the importance of the R349 gene in the
MIMIVIRE system, we developed and presented, for the first time to our knowledge,
a protocol for Mimivirus genomic editing. By knocking out R349 gene in a Mimivirus
lineage A, we observed the replication of Zamilon, indicating that this gene is critical in
the resistance against this specific group of virophages.
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INTRODUCTION
In recent years, several studies have shown that the endogenization of pathogen sequences
to prevent their multiplication is a main mechanism of defense for living organisms. This
phenomenon has been intensively discussed in the context of vertebrates evolution, where the
number of integrated retroviruses reaches several thousand per organism (Colson et al., 2014). The
current retrovirus epidemic in koalas is a good example of the endogenization process (integration
and transmission to the progeny of the KoRV) that protects offspring from infection by these
retroviruses (Tarlinton et al., 2006).
Bacteria and archaea have evolved several immune strategies to defend themselves against
viruses, which are the most abundant biological entities in the biosphere (Suttle, 2005, 2007; Rohwer
and Thurber, 2009; Horvath and Barrangou, 2010). These immune strategies have been classified
into innate and adaptive defense systems (Koonin et al., 2016). The innate immunity systems are
represented by diverse types of restriction modification (RM) systems, while the CRISPR (clustered
regularly interspaced short palindromic repeats)-Cas (CRISPR-associated genes) system is the
unique adaptive immune mechanism that mediates defense against viruses (Orlowski and Bujnicki,
2008; Karginov and Hannon, 2010).
The CRISPR-Cas defense system involves the excision of DNA fragments from alien sequences
and their integration into CRISPR arrays (Sorek et al., 2008; Koonin and Makarova, 2009;
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van der Oost et al., 2009; Deveau et al., 2010; Horvath and
Barrangou, 2010; Karginov and Hannon, 2010; Makarova et al.,
2011). This mechanism is known as the adaptation and requires
the intervention of the Cas machinery. The integrated sequences
(spacers) create an immune memory capable of protecting the
host cell during new encounters with the invading agents.
Indeed, the processed transcripts of the spacers are used as
guides for the Cas nucleases (effector) to recognize and cleave
the target genome. This immune system is highly specific and
protects diverse bacterial organisms from a wide variety of
invading nucleic acids like phages. The latter are involved in
a permanent arms race with their prey by developing various
immune evasion strategies. Perhaps the most astonishing strategy
is to counterattack an innate bacterial defense mechanism by
encoding a complete CRISPR-Cas response (Seed et al., 2013).
The discovery of giant viruses of amoeba has challenged our
definition of what a virus is (La Scola et al., 2003; Colson et al.,
2018). In addition to the giant size of their capsids and genomes,
giant viruses of the family Mimiviridae have been shown to
be, themselves, the prey of other viruses, thus highlighting a
prominent turn of events in the virology field (Raoult et al., 2004;
La Scola et al., 2008; Colson et al., 2017). The newly discovered
viruses of giant viruses were named virophages because of their
functional analogy with bacteriophages. Virophages parasitize
the viral factory of giant viruses supposedly by hijacking the
transcription and replication apparatus of their host virus to
express and replicate their own genomes (Claverie and Abergel,
2009). Sputnik is the first isolated virophage and was able to infect
the three phylogenetic groups that cluster in the Mimiviridae
family (group A, B, and C) (Gaia et al., 2013). In contrast,
Zamilon, the second isolated virophage, was able to replicate with
mimiviruses from group B and C, but not with those belonging to
group A (Gaia et al., 2014).
The selective resistance of Mimivirus group A to Zamilon
virophage led us to look for integrated sequences of virophages
that we described as “MIMIVIRE” for Mimivirus virophage
resistance element. Different from the CRISPR to which it has
been compared by analogy, the MIMIVIRE operon contains a
gene named R349 with 4 small repeats of the virophage targets
(Levasseur et al., 2016). The silencing of 3 genes from the
MIMIVIRE operon (encoding a helicase-like gene, a nuclease-like
gene and the gene containing repeats) abolished the MIMIVIRE
activity, a phenomenon that we have characterized as the result
of an adaptive defense system (Levasseur et al., 2016). This
hypothesis has been controversial in the literature (Claverie
and Abergel, 2016). However, nuclease and Mimivirus helicases
have already been expressed to identify their role, and a new
recent study reported, after expression and crystallization, that
the nuclease has a Cas-4 activity (Bekliz et al., 2016; Dou
et al., 2018). On the other hand, the molecular bases of the
interference mechanism mediated by the MIMIVIRE system
remain enigmatic, notably the role of the repetitive sequences.
We have recently isolated and sequenced a new Mimivirus
lineage A strain from a Human sample (Moal et al., 2018). Here,
we analyzed its genome and identified a divergent MIMIVIRE
operon. Indeed, the R349 gene in this virus does not present the
repeated pattern observed in the other mimiviruses of lineage
A. We then investigated the functional consequence of the
absence of the repetitive motif by testing the sensibility of this
new Mimivirus strain to Zamilon virophage. To reinforce the
importance of the R349 gene in the MIMIVIRE system, we
developed and presented, for the first time to our knowledge,
a protocol for Mimivirus genomic editing. By knocking out
R349 gene in Acanthamoeba Polyphaga Mimivirus (APMV), we
observed the replication of Zamilon, indicating that this gene is
critical for the resistance against this specific group of virophages.
MATERIALS AND METHODS
Mimivirus Strain U306 and Zamilon
Virophage Production
Mimivirus Strain U306 Production and Genome
Analysis
Acanthamoeba castellanii trophozoites at a concentration of 5.105
cell/ml in PYG (Peptone yeast extract glucose) medium were
used to produce Mimivirus U306 and APMV (La Scola et al.,
2003; Moal et al., 2018). A Multiplicity of infection (M.O.I.) of
10 TCID50 (median Tissue Culture Infectious Dose) was used to
infect the host cells with each virus strain. After 48 h of incubation
at 32◦C, the virus suspension was centrifuged at 1000 g for
10 min. The supernatant containing the virus progeny was then
filtered across a 0.8 µm membrane to remove residual amoebas
and cysts. For a second time, the virus suspension was washed
three times with Page’s modified Neff’s amoeba saline (PAS)
medium by high-speed centrifugation (10,000 g for 10 min) to
pellet the virus particles.
The genome of Mimivirus U306 was previously submitted
to the EMBL-EBI database under accession number LT717347.
Here, GeneMarkS was used for the prediction of coding DNA
sequences. The R349 homologs in Mimivirus U306 were found
using BLASTn searches (Basic Local Alignment Search Tool).
Zamilon Virophage Production
Megavirus Courdo 11 was used to produce Zamilon virophage
by co-culture in A. castellanii within PYG medium (La Scola
et al., 2010). The co-culture was incubated at 32◦C until complete
lysis of cells. The virus-virophage suspension was centrifuged
at 10,000 g for 10 min and successively filtered through 0.8,
0.45, and 0.22 µm pore filter to remove giant virus particles
and residual amoebas. The Zamilon particles were concentrated
by ultracentrifugation (60,000 g for 2 h) and the pellet was
then resuspended with PAS medium. In the last step, the
highly concentrated virophage suspension was submitted to a
final round of ultracentrifugation (60,000 g for 2 h) across
a 15% sucrose layer to obtain a pure Zamilon pellet, which
was resuspended in 1 ml PAS medium and stored at –80◦C.
The absence of giant virus particles was confirmed by negative
staining electron microscopy.
APMV R349-KO Viruses
Plasmid Construction for Knock-Out Experiments
The R349 gene in APMV was knocked out by homologous
recombination method in amoebas infected with APMV and
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TABLE 1 | Primers used for R349 flanking regions cloning into PLW44 vector.
Primers Sequencesa
FwPLW F1 EcoRI 5′AACTCTTAGAATTCGGATATTTTGAATTGTCTGTTCA3′
RvPLW F1 EcoRI 5′TTATGTAGAATTCTTTGGAAGGTGAAATTTATATGTA3′
FwPLW F2 SmaI 5′CAACAATCCCGGGTCCACTAAATTAATCTCCGATATT3′
RvPLW F2 PstI 5′AAGATCTCTGCAGCATGGATCATTATGTAGTGACGCT3′
aRestriction sites are underlined.
transfected with the recombination vector. The backbone of
this vector was the PLW44 plasmid (kindly provided by Dr.
Flávio da Fonseca, Universidade Federal de Minas Gerais),
which contains enhanced green fluorescent protein (eGFP)
gene as reporter, under the control of an AT-rich promoter
region, similar to the promoter motif predicted for mimiviruses
(Claverie, 2005; Abrahão et al., 2018). We inserted both the
upstream and downstream regions of mimivirus R349 gene into
PLW44, flanking the eGFP gene and its promoter. The APMV
R349 flanking regions (500 bp each) were separately amplified
by PCR and sub-cloned into pGEMT-easy vector (Promega,
United States). The details of the primers used are listed in
Table 1. These plasmids were propagated in Escherichia coli
DH5alpha and were then extracted by using Minipreps plasmid
extraction kit (Promega, United States). The R349 flanking
regions were released from pGEMT-easy vector after digestion
with EcoRI (flanking region 1) and SmaI/PstI (flanking region
2) (Promega, United States). In parallel, the vector PLW44
was digested with the same enzymes and the fragments were
then inserted (T4 DNA ligase, Promega, United States). After
one round of PLW44-eGFP-Flank1/2 propagation in Escherichia
coli DH5alpha, the vector was purified as previously described,
quantified in nanodrop1000 spectrophotometer (Thermo Fisher
Scientific, United States) and stored at−80◦C until use.
Transfection and Virus-Vector Recombination
Prior to transfection, fresh Acanthamoeba castellanii cells (ATCC
30010) were washed twice with peptone-yeast-glucose (PYG)
medium, one million cells were centrifuged at 1200 g for 10 min
and the media was removed. Cells were resuspended in 2 ml PYG
medium and placed in a six-well culture plate (Thermo Fisher
Scientific, United States). DNA was prepared for transfection
as follows: one microgram of PLW44-eGFP-Flank1/2 plasmid
was incubated with 15 µl Lipofectamine 3000 reagent (Thermo
Fisher Scientific, United States) and PYG medium, according
to the manufacturer’s instructions. 3 × 106 TCID50 APMV
was added, and the solution was mixed gently by pipetting
up and down. The mixture was added to the cells in a six-
well culture plate. The cells were then incubated at 32◦C, and
after complete cell lysis (after 48 h approximatively) the extract
containing recombinant (KO R349) and wild-type (WT) viruses
was collected and stored at−80◦C.
APMV R349-KO Viruses Screening
First, specific PCR systems targeting the recombinant virus were
designed and performed on the DNA extracted from the previous
step, in order to confirm the insertion of the eGFP gene instead
TABLE 2 | Primers used for KO-R349 recombinant viruses
screening and sequencing.
Primers Sequences
Fw-KO-Up 5′CTTGTTGAATTGGGTCTTGGTC3′
Rv-KO-Up 5′GAACAGCTCCTCGCCCTTG3′
Fw-KO-Dw 5′AGATCCGCCACAACATCGAG3′
Rv-KO-Dw 5′CTTGGATCACGTCCCAACCA3′
Fw-R349-screening 5′GGATGTCGTAATTGTGCCTGA3′
Rv-R349-Screening 5′AGGCCCATCACCAAAACCAA3′
Fw-GFP-screening 5′GGCAAGCTGACCCTGAAGTT3′
Rv-GFP-screening 5′CTTGTAGTTGCCGTCGTCCT3′
the R349 gene (Table 2). One million of fresh A. castellanii was
then infected in a 25 cm2 flask with 1 ml of extract of viruses
obtained in the transfection experiment (containing both R349-
KO and wild type populations). After 30 min of adsorption, the
inoculum was removed and 5 ml of Page’s modified Neff’s amoeba
saline (PAS) was added to the flask. The infected cells were
incubated for 8 h at 32◦C, and were then detached from the flask,
centrifuged for 10 min, 1200 g, and the pellet was resuspended in
500µl of PAS buffer. This time point represents a late phase of the
Mimivirus cycle where virion morphogenesis has already begun
and fully assembled viral progeny have already been observed
in Mimivirus infected cells (Suzan-Monti et al., 2007; Andrade
et al., 2017). In parallel, the same procedure was performed
using APMV wild-type infected amoebas. The infected cells
were then submitted to BD FACS Scan flow cytometer (BD,
United States) for recombinant viruses screening and sorting.
We sorted between 1,000 and 2,000 cells. The eGFP fluorescence
cutoff was defined based on uninfected and APMV wild-type
infected cells. The amoebas presenting a level of fluorescence
higher than the defined-cut off were selected, sorted and collected
in PAS solution (Supplementary Figure S1). These cells were
transferred to a 25 cm2 flask containing one million of fresh
amoebas and incubated for 48 h at 32◦C.
The lysate containing the R349 KO recombinant viruses
was collected and submitted to five more rounds of clonal
purification. To this end, 500,000 A. castellanii were infected in
25 cm2 flask with the lysate produced during the last step (MOI
of 1 TCID50). After 30 min, the inoculum was removed, the
cells were centrifuged for 10 min at 1200 g and the pellet was
resuspended in 100 µl. These cells were then inoculated onto a
non-nutrient agar plate, covered by fresh heat-inactivated E. coli
DH5-alpha (Invitrogen, United States). The inoculation was
performed equidistantly by dropping nine 10 µl droplets of the
resuspended pellet. The plate was then incubated for 8 h at 32◦C.
At this point, it was possible to observe the amoeba’s movement
onto the agar surface. Under an optical microscope, isolated
amoebas were marked with a pen (without opening the plate) and
were then collected individually with a small tip or needle under
sterile conditions. Each collected amoeba was transferred to a
well containing 40,000 fresh amoebas in a 96 well plate (200 µl
of PAS buffer per well). After 24 h of incubation at 30◦C, the
wells were observed under a microscope to check for cytopathic
effects (CPE). In wells where the CPE was observed, 30µl aliquots
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of each viral suspension were collected and submitted to DNA
extraction using the EZ1 DNA Tissue Kit (Qiagen, Germany)
according to the manufacturer’s instructions. Screening PCRs
targeting R349 or eGFP gene were then performed to confirm
the recombination and the lack of contamination with the wild-
type (Table 2), the products were visualized on an agarose
1% gel using SYBR safe buffer (Invitrogen, United States). The
remaining 170 µl were used for four new rounds of recombinant
viruses screening and purification. After the final round of KO
virus purification, the remaining 170 µl containing only KO
virus were transferred to a 25 cm2 flask with 500,000 of fresh
amoebas and incubated for 48 h at 32◦C to propagate the KO
virus. After lysis, a small background of WT viruses was detected
by qPCR. This probably indicate that a very small amount
of WT virus was present in the last cycle of the purification
process but was not detected by the R349-PCR system due to
its low concentration. This production containing a mixture of
KO and WT viruses was used to perform Mimivirus-virophage
permissiveness experiments. A MOI of 1 TCID50 of KO virus
was used for the virophage permissiveness assay to reduce the
WT contamination and avoid the co-infection WT-KO virus.
We are currently working to improve our purification system,
by adding selection factors to genetic constructions, such as
geneticin (ongoing).
Regarding the construction of the APMV R349-revertant
virus, the same procedures were performed. However, the lack
of eGFP and the presence of R349 were the selected screening
factors, by using fluorescence detection and PCR (Table 2). The
plasmid used for R349-revertant construction was rescued after
the homologous recombination of PLW44-eGFP-Flank1/2 and
APMV. An aliquot of this cell extract was submitted to DNA
extraction and electrophoresis, and the band corresponding to
the plasmid was then recovered from the 1% agarose gel (Qiagen
gel extraction kit), transformed in E. coli DH5alpha, propagated
and purified as previously described. This plasmid was used to
re-insert the R349 gene into the genome of KO R349 Mimivirus
by homologous recombination, as described above. All plasmids
and recombinant (viral) regions described in this work were
sequenced 4 times to confirm the absence of mutations in the
related ORFs, rescue markers and flanking regions.
To check the presence/absence of eGFP protein in the extract
of cells infected (8 h post-infection) with APMV-R349-KO,
APMV R349-revertant or APMV-Wild-type, western-blot assays
were performed using anti eGFP and anti-Beta-actin antibodies
(F56-6A1.2.3 and AC-15 ab6276 – Abcam) (Figure 1).
Zamilon Infection of APMV,
APMV-R349-KO, APMV R349-Revertant,
and Mimivirus U306
To check whether Mimivirus U306, APMV R349-KO, or
APMV R349-revertant are permissive to Zamilon replication, the
infections were prepared as described by Levasseur et al. (2016).
The experiment was carried out three times independently,
in duplicate. DNA extraction and PCRs were performed as
described by Levasseur et al. (2016) as well and analyzed by 1Ct
method considering times 0 and 24 h post-infection. The results
FIGURE 1 | eGFP and amoebal beta-actin detection by western blot.
A. castellanii cells were infected with APMV-Wild-type, APMV-R349-KO (two
different clones) and APMV R349-revertant at M.O.I. of 10 TCID50. The cells
were collected 8 h post-infection, submitted to protein extraction and then to
western-blot targeting eGFP and amoebal beta-actin. The figure shows that,
as expected, APMV-R349-KO clones express eGFP.
were then expressed in Relative quantification (quantification
of the increase in Zamilon DNA concentration at H24, relative
to its concentration at H0). Transmission electron microscopy
experiments were conducted to assess Zamilon growth observed
by qPCR with Mimivirus U306. Co-infected cells were washed
three times with phosphate-buffered saline (PBS) solution and
fixed overnight with 2% glutaraldehyde in 0.1 M cacodylate
buffer. Cell pellet was then washed three times with 0.1 M
cacodylate buffer, and subsequently fixed for 1 h with 1% osmium
tetroxide in 0.1 M potassium ferricyanide solution. After three
successive washes in distilled water, samples dehydration was
performed in increasing ethanol concentrations (30, 50, 70, 96,
and 100%) before embedding in Epon 812 resin. Sections (70 nm)
were finally post-stained with 3.5% uranyl acetate and lead citrate
before examination with a transmission electron microscope.
RESULTS
In a previous large-scale survey, aimed at reporting the presence
of a giant virus in the urine of 480 kidney transplant recipients,
we reported the isolation of a new member of the Mimiviridae
family (Moal et al., 2018). The phylogenetic tree based on
DNA-dependent RNA polymerase gene has classified this new
Mimivirus (Mimivirus U306) in the lineage A of the Mimiviridae
family (Moal et al., 2018).
The genome of Mimivirus U306 available in the EMBL-
EBI database under accession number LT717347 has now
been analyzed. Coding DNA sequences were predicted using
GeneMarkS. We found that Mimivirus U306 genome contains
936 predicted genes.
We then analyzed the Mimivirus U306 genes for the presence
of a MIMIVIRE system hallmark, a common feature found in
all mimiviruses genomes from lineage A described so far. The
ortholog of R349 in Mimivirus U306 consists of two different
genes, respectively, ORF 363 and ORF 364. We identified a
truncated copy of the MIMIVIRE system sequence, scattered
between these genes (Figure 2 and Supplementary Table S1).
Indeed, the ORF 363 gene contains a 21-nucleotide-long
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FIGURE 2 | Comparison of the MIMIVIRE sequences between Mimivirus U306 and APMV. Mimivirus U306 lacks the repetitive motifs and presents a truncated
MIMIVIRE sequence compared to APMV and the other Mimiviruses lineage A. Mutations are indicated by white lines.
FIGURE 3 | The replication of Zamilon in Acanthamoeba castellanii co-infected with Mimivirus U306 or APMV. (A) Graph depicting the replication of the virophage
with Mimivirus U306 or APMV measured after 24 h by qPCR. Delta Ct corresponds to the difference between Ct value specific to virophage at H0 and H24. (B,C)
Transmission electron microscopy images after 16 h of Zamilon infection. (B) Zamilon was able to infect and replicate within the viral factories of Mimivirus U306
(arrows). (C) No virophage progeny was observed in the viral factories of APMV. ∗∗Student’s t-test, p < 0.005.
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FIGURE 4 | Homologous recombination strategy used to create APMV KO-R349 and APMV R349 revertant. The R349 gene was replaced by the eGFP marker
derived by the AT-rich promoter to generate the APMV KO-R349 mutant. APMV R349 revertant was created by re-inserting the R349 gene in APMV KO-R349
instead of the eGFP sequence.
sequence of Zamilon instead of the 28 nucleotide sequence found
in the classical MIMIVIRE system (Levasseur et al., 2016). We
found that this 21-nucleotide-long stretch presents 3 mismatches
compared to the original 28 nucleotide sequence located in
open reading frame 4 (ORF 4) of the Zamilon genome and the
R349 of the other mimiviruses from the group A (Figure 2 and
Supplementary Figure S2). Moreover, the repetitive motifs are
lost in the Mimivirus U306 MIMIVIRE copy as the ORF 364 gene
only contains a single copy of the 15-nucleotide sequence that was
identical to Zamilon, versus four repeated copies described in the
MIMIVIRE of the other mimiviruses lineage A (Figure 2). This
single 15 nucleotide repeat perfectly matched the four repeated
sequences (and thus the initial 28 nucleotide sequence) found in
the R349 of APMV and the other mimiviruses A (Supplementary
Figure S2). Using the quantitative PCR, we observed for the first
time the permissiveness of a lineage A Mimivirus to Zamilon
with an increase in the DNA concentration of the Zamilon
virophage after 24 h post-infection and observation of Zamilon
particles infecting the viral factory of the Mimivirus (Figure 3). In
addition, real-time PCR and transmission electronic microscopy
confirmed the results of previous studies showing that Zamilon
is not able to replicate in mimiviruses from lineage A including
APMV (Figure 3).
The second aim of this work was to reinforce the importance
of the R349 gene in the resistance against Zamilon. Indeed,
although its implication has been validated in the initial
MIMIVIRE study by silencing experiment with small interfering
RNAs (siRNAs) (Levasseur et al., 2016), one might suppose that
the permissiveness of Mimivirus A to Zamilon has been induced
by the knock-down of an unintended target within amoeba or
Mimivirus. We therefore first confirmed the absence of sequences
identical to those silenced in the amoeba by similarity searches.
By knocking-out R349 gene from the APMV genome, we were
able to confirm and highlight the central role of the R349 gene
in the defense mechanism against Zamilon. We have created a
Mimivirus deletion mutant lacking the R349 gene by homologous
recombination, in which the enhanced green fluorescent protein
gene has been inserted to replace the Mimivirus R349 gene
(Figure 4). The insertion of eGFP marker in the appropriate
locus, instead of the R349 gene, was confirmed by using 2
specific PCR systems (Figure 5). The first primer pair, Fw-KO-
Up and Rv-KO-Up, were designed to amplify the recombination
product upstream of the eGFP. In this system, Fw-KO-Up targets
the R348 gene (outside the flanking region1), while Rv-KO-Up
targets the eGFP (Figure 5). On the other side, Fw-KO-Dw and
Rv-KO-Dw were designed to specifically target a sequence in the
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FIGURE 5 | Specific PCR characterization of the recombinant KO-R349 obtained from the transfection experiment. Two specific PCR systems were used to confirm
the recombination and the insertion of eGFP instead of the R349 gene in the KO-R349 mutant. The first system, KO-Up, targets recombination upstream of the
R349 gene (A), while the second system, KO-Dw, targets recombination downstream of the target gene (B). (1) DNA extracted from the lysate obtained in the
transfection experiment, (2) DNA extracted from Acanthamoeba castellanii cells infected with the APMV wild type, (3) PLW44-eGFP-Flank1/2 plasmid was used as
template for the PCR, (4) negative control (nuclease-free water).
eGFP and a region in the R350 gene downstream of the flanking
region 2, respectively (Figure 5). The product of each system
was sequenced and confirmed the success of the recombination
(The primers used for the PCR and sequencing experiments are
listed in Table 2).
After rounds of screening and sorting by flow cytometry
and PCR targeting recombinant viral clones (Supplementary
Figure S1), the KO R349 Mimivirus was submitted to assays to
check its permissiveness to Zamilon virophage in Acanthamoeba,
as described by Levasseur et al. (2016). In addition, APMV-
wild type and a revertant virus (in which the R349 gene
was re-inserted instead of eGFP as shown in Figure 4) were
assayed. After 24 h post-infection, we observed a ∼25-fold
increase in the Zamilon genome load in cells co-infected
with the R349-KO virus (Figure 6). In contrast, we could
not observe Zamilon genome replication in cells co-infected
with APMV-wild type, nor in cells co-infected with the
revertant virus. For the latter, a slight increase in Zamilon
DNA concentration was observed compared to the APMV-
wild type (less than 0.5 PCR cycle difference between revertant
APMV and APMV-wild type) (Figure 6). Such a difference
probably does not seem significant and therefore unreliable
to draw a strong conclusion. Otherwise, one might suppose
that this increase could be explained by the presence of a
small background of KO-R349 virus in the revertant Mimivirus
production, which allowed the Zamilon virophage to replicate.
FIGURE 6 | Graph depicting the replication of Zamilon DNA in A. castellanii
co-infected with APMV KO-R349, APMV-WT, or APMV R349 revertant. The
replication of each virophage was measured after 24 h using qPCR. Delta Ct
corresponds to the difference between Ct value specific to virophage at H0
and H24. ∗∗Student’s t-test, p < 0.005.
These results were reinforced by negative staining microscopy,
in which a substantial amount of virophage particles were
observed only in cells co-infected with the R349-KO virus
(data not shown).
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DISCUSSION
In this study, we presented evidences of the role of the
repetitive sequences in the resistance mechanism mediated by the
MIMIVIRE system against Zamilon virophage. We demonstrated
that the new Mimivirus U306, which has a MIMIVIRE sequence
containing a single repeat instead of 4 virophage repeats, is
permissive to Zamilon infection. This finding is evocative to
what has been observed for the bacterial CRISPR-Cas system.
Indeed, it has been shown that the addition of multiple spacers
targeting the same phage sequence in the CRISPR-array of
Streptococcus thermophilus can increase the level of its resistance
to the phage (Barrangou et al., 2007). We speculate that the
number of four repeats in MIMIVIRE increases the probability
that the repeat transcript identifies the target sequence and
thus triggers the interference mechanism. However, further
experiments are required to validate this hypothesis. In addition,
it has also been reported that S. thermophilus mutant, which
contains a single repeat rather than the repeated consensus in
the CRISPR-array, was also sensitive to the phage despite the
presence of spacers targeting it (Barrangou et al., 2007). These
results, along with our observations, probably indicate that the
interference mechanism of both MIMIVIRE and CRISPR-Cas
systems require that the target sequence (spacer for CRISPR
and repeat for MIMIVIRE) should be inserted into a specific
genetic context. This genetic context may be the succession of
a few target repeats for MIMIVIRE, versus alternation repeat-
spacer in CRISPR. On the other hand, the 28-nucleotides
Zamilon sequence found in the classic MIMIVIRE consists in
Mimivirus U306 of only 21-nucleotides sequence presenting
several mutations compared to the target in Zamilon. In some
CRISPR-Cas system types, a perfect match is required between
the spacer and the protospacer for target recognition and
resistance. A single polymorphism between the spacer and the
target sequence has been shown to be sufficient to allow the
phage to infect the CRISPR-immunized bacterial host (Barrangou
et al., 2007; Deveau et al., 2008). Therefore, the presence of
mutations could be one of the causes of permissiveness to
Zamilon, or the fact that the MIMIVIRE sequence is truncated
in between two genes in the U306 Mimivirus genome. Recently,
an alternative scenario to the adaptive immune system has
been proposed to explain the mechanism of resistance of
Mimivirus lineage A to Zamilon (Claverie and Abergel, 2016).
The process of Zamilon inhibition has been interpreted by a
protein interference, mediated by a restriction factor analog,
which is encoded by the R349 gene. According to this model,
this restriction factor-like protein is supposed to use the repeat
motifs to interfere with the action of its target in Zamilon
virophage. Although experimental demonstrations are required
to verify this hypothesis, the permissiveness of Mimivirus U306
to Zamilon would not question it. Furthermore, as described
above, the homolog of R349 gene in Mimivirus U306 presents
several mutations that cut it into two separated genes. Therefore,
this gene is no longer functional and therefore no longer
produces the putative restriction factor-like required for the
defense against Zamilon infection. One might suppose that
this alleviate the protein-mediated inhibition and thus allows
Zamilon to replicate in Mimivirus U306. In addition, we screened
here the R349 orthologous proteins in Mimivirus U306 for the
presence of the peptidic motif “Asp-Asn-Glu-Ser” (DNES), that
has previously been predicted to be implicated in the protein-
based interference mechanism (Claverie and Abergel, 2016).
Interestingly, we identified only one copy of the “DNES” motif
in Mimivirus U306 (located in the ORF 364 gene) instead of six
copies found in the R349 gene of APMV. On the other hand,
ORF4 of Zamilon (putative target of MIMIVIRE) has been shown
to contain two copies of DNES motif (Claverie and Abergel,
2016), which is higher than what is found in Mimivirus U306.
This finding raises probably an alternative scenario in which
the occurrence of mutations in the R349 homolog of Mimivirus
U306 causes this gene product to lose the repeated peptidic motif
implicated in the antagonist activity against the ORF4 product
of Zamilon. This probably allows the ORF4 protein to trigger
the proteins-interactions necessary for the expression and the
replication of Zamilon virophage.
Afterward, we performed homologous recombination to
knock-out the R349 gene of Mimivirus by replacing it with the
enhanced green fluorescence protein (eGFP) gene. This latter
was used during the process of selection and purification of
the recombinant clone. At the end of the fluorescence-based
selection process, we obtained a recombinant Mimivirus lacking
the R349 gene. Our results confirm that the R349 gene has a
critical role in the resistance of Mimivirus lineage A to Zamilon,
since this latter was able to infect and replicate with R349-
deficient Mimivirus. This observation was strongly confirmed by
generating the R349-revertant Mimivirus that was resistant to
Zamilon by knocking-in the R349 gene in the genome of the R349
deficient strain (in the same locus). Unfortunately, since selection
is made on fluorescent virus factories, not on single fluorescent
virus particles, and in the absence of a pressure selection system, it
was not possible to obtain stable R349-KO viruses. Nevertheless,
this first transformation of a giant virus is encouraging. In the
future, we will have to look for a selection system that allows us
to obtain stable transformed viruses.
CONCLUSION
In conclusion, we demonstrated herein that the R349 gene
contained within the MIMIVIRE system is crucial for
the protection of the Mimivirus lineage A from Zamilon
infection. We additionally highlighted the functional role of the
integrity of the R349 in the process of resistance to Zamilon
by demonstrating that mimiviruses that lack the repetitive
consensus and present mutations in this gene are susceptible
to virophage. In the future, it would be an obvious option to
use the protocol of genome editing described here to generate
some derivative constructs, like mimiviruses containing partial
R349 sequences. This would allow to determine precisely which
element in the R349 gene is relevant in conferring the resistance
(perfect match to the Zamilon sequence and/or number of
repetitions). Another interesting point that could be investigated
in the future is the effect of Zamilon on the replication cycle of
Mimivirus U306 and the KO-R349 virus. Indeed, although this
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virophage was not able to affect mimiviruses from lineage B and
C, its impact on mimiviruses lineage A has never been explored
(Since it was not able to infect any virus from this lineage).
We believe that studying its involvement would give insight to
understand why only mimiviruses from lineage A have evolved a
defense system against this virophage.
These elements reinforce the MIMIVIRE system and make
it possible to propose that giant viruses, like other organisms,
be involved in an arms race to survive and multiply despite
parasitism, including that of the virophage.
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FIGURE S1 | APMV R349-KO infected amoebas screening and sorting by BD
FACS Scan flow cytometer. The cutoff was defined based on the background
fluorescence detected in uninfected and APMV-wild-type infected cells.
FIGURE S2 | Sequence homology representation between different Zamilon
sequences present in the MIMIVIRE of APMV and U306 strain. The 28-nucleotides
sequence of Zamilon present in the initial R349 gene of mimiviruses A is shortened
to a sequence of 21 nucleotides with 3 mismatches (in red) in the ORF 363 of
Mimivirus U306 strain. The repeat of 15 nucleotides (albeit single) located in the
ORF 364 match perfectly the original 28-nucleotides sequence (and thus the four
repeated sequence) found in the other mimiviruses from lineage A.
TABLE S1 | Nucleotide and protein sequences of the Mimivirus U306 MIMIVIRE
copy and their annotation.
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